Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors

References

• World Health Organization, Fact sheet No. 297, February 2009. Cited 2011. Ref Type: Generic.
   Google Scholar
• El-Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 2004;127:S27–34.
   PubMed Web of Science ®Google Scholar
• Fuss M, Thomas CR, Jr. Stereotactic body radiation therapy: An ablative treatment option for primary and secondary liver tumors. Ann Surg Oncol 2004;11:130–8.
   PubMed Web of Science ®Google Scholar
• Fujiki M, Aucejo F, Kim R. General overview of neo- adjuvant therapy for hepatocellular carcinoma before liver transplantation: Necessity or option? Liver Int 2011;31:1081–9. doi: 10.1111/j.1478-3231.2011.02473.x.
   PubMedGoogle Scholar
• Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: A literature review. Int J Hepatol Epub 2011 May 11. doi:10.4061/2011/104685.
   Google Scholar
• Kuang M, Xie XY, Huang C, Wang Y, Lin MX, Xu ZF, . Long-term outcome of percutaneous ablation in very early-stage hepatocellular carcinoma. J Gastrointest Surg 2011;15:2165–71.
   PubMed Web of Science ®Google Scholar
• Oliveri RS, Wetterslev J, Gluud C. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev 2011;3:CD004787.
   PubMedGoogle Scholar
• Young RF. The role of the gamma knife in the treatment of malignant primary and metastatic brain tumors. CA Cancer J Clin 1998;48:177–88.
   PubMed Web of Science ®Google Scholar
• Lo SS, Dawson LA, Kim EY, Mayr NA, Wang JZ, Huang Z, Cardenes HR. Stereotactic body radiation therapy for hepatocellular carcinoma. Discov Med 2010;9:404–10.
   PubMed Web of Science ®Google Scholar
• Dawson LA, Eccles C, Bissonnette JP, Brock KK. Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control. Int J Radiat Oncol Biol Phys 2005;62:1247–52.
   PubMed Web of Science ®Google Scholar
• Yu C, Main W, Taylor D, Kuduvalli G, Apuzzo ML, Adler JR Jr. An anthropomorphic phantom study of the accuracy of Cyberknife spinal radiosurgery. Neurosurgery 2004;55: 1138–49.
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Näslund I, Svanström R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861–70.
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Goranson H, Kraepelien T, Nilsson B, Naslund I, . Radiosurgery for tumors in the body: Clinical experience using a new method. J Radiosurg 1998;1: 63–74.
   Google Scholar
• Cardenes HR, Price TR, Perkins SM, Maluccio M, Kwo P, Breen TE, . Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol 2010;12:218–25.
   PubMed Web of Science ®Google Scholar
• Herfarth KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P, . Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol 2001;19:164–70.
   PubMed Web of Science ®Google Scholar
• Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005;62:1371–8.
   PubMed Web of Science ®Google Scholar
• Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, . Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 2008;26:657–64.
   PubMed Web of Science ®Google Scholar
• Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, . Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 2010;78:486–93.
   PubMed Web of Science ®Google Scholar
• Goyal K, Einstein D, Yao M, Kunos C, Barton F, Singh D, . Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: Preliminary results. HPB Surg 2010;2010. pii: 309780.
   Google Scholar
• Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007;67:793–8.
   PubMed Web of Science ®Google Scholar
• Milano MT, Katz AW, Muhs AG, Philip A, Buchholz DJ, Schell MC, . A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2008;112:650–8.
   PubMed Web of Science ®Google Scholar
• Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, . Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2011; 81:e447–53.
   PubMed Web of Science ®Google Scholar
• Chan LC, Chiu SK, Chan SL. Stereotactic radiotherapy for hepatocellular carcinoma: Report of a local single-centre experience. Hong Kong Med J 2011;17:112–8.
   PubMedGoogle Scholar
• Choi BO, Jang HS, Kang KM, Lee SW, Kang YN, Chai GY, . Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. Jpn J Clin Oncol 2006; 36:154–8.
   PubMedGoogle Scholar
• Choi BO, Choi IB, Jang HS, Kang YN, Jang JS, Bae SH, . Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: Preliminary analysis. BMC Cancer 2008;8:351.
   PubMed Web of Science ®Google Scholar
• Kwon JH, Bae SH, Kim JY, Choi BO, Jang HS, Jang JW, . Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer 2010;10:475.
   PubMed Web of Science ®Google Scholar
• Louis C, Dewas S, Mirabel X, Lacornerie T, Adenis A, Bonodeau F, . Stereotactic radiotherapy of hepatocellular carcinoma: Preliminary results. Technol Cancer Res Treat 2010;9:479–87.
   PubMed Web of Science ®Google Scholar
• Mendez RA, Wunderink W, Hussain SM, de Pooter JA, Heijmen BJ, Nowak PC, . Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study. Acta Oncol 2006;45:831–7.
   PubMed Web of Science ®Google Scholar
• Park JS, Lee DH, Jeong S, Kim WC, Lee JI, Lee SY, . Concurrent chemoradiation in a patient with unresectable cholangiocarcinoma. Gut Liver 2010;4:103–5.
   PubMedGoogle Scholar
• Sato M, Uematsu M, Yamamoto F, Shioda A, Tahara K, Fukui T, . Feasibility of frameless stereotactic high-dose radiation therapy for primary or metastatic liver cancer. J Radiosurg 1998;1:233–8.
   Google Scholar
• Seo YS, Kim MS, Yoo SY, Cho CK, Choi CW, Kim JH, . Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma. J Surg Oncol 2010;102:209–14.
   PubMed Web of Science ®Google Scholar
• Son SH, Choi BO, Ryu MR, Kang YN, Jang JS, Bae SH, . Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: Dose-volumetric parameters predicting the hepatic complication. Int J Radiat Oncol Biol Phys 2010;78:1073–80.
   PubMed Web of Science ®Google Scholar
• Wada H, Takai Y, Nemoto K, Yamada S. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys 2004;58:1114–20.
   PubMedGoogle Scholar
• Wulf J, Guckenberger M, Haedinger U, Oppitz U, Mueller G, Baier K, . Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 2006;45: 838–47.
   PubMed Web of Science ®Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, . New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205–16.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, . New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.
   PubMed Web of Science ®Google Scholar
• McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2009;73:112–8.
   PubMed Web of Science ®Google Scholar
• Rule W, Timmerman R, Tong L, Abdulrahman R, Meyer J, Boike T, . Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol 2011;18:1081–7.
   PubMed Web of Science ®Google Scholar
• Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, . Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009;27: 1585–91.
   PubMed Web of Science ®Google Scholar